retatrutide parkinson's disease clinical trial nct The NADPARK study: A randomized phase I of nicotinamide riboside supplementation in Current Therapies in Trials – First Retatrutide phase 3 data,

Prediction of the effects of liraglutide on kidney and cardiovascular outcomes based on short-term changes in multiple risk markers

doi: 10.1056/NEJMp1314078 68 Pi-SunyerXAstrupAFujiokaKGreenwayFHalpernAKrempfMet al

CrystEngComm 17:456462 Rojas S, Garca-Garca A, Hidalgo T, Rosales M, Ruiz-Camino D, Salcedo-Abraira P et al (2022) Antibacterial activity of two Zn-MOFs containing a tricarboxylate linker

Discussing genetic predispositions alongside clinical history, vital signs, and lab work can support a more personalized approach to medication selection and dosing

"Your body actually does produce GLP-1 naturally," said Debussy